
GC65874
Medroxalol
Also known as 5-[2-[4-(1,3-benzodioxol-5-yl)butan-2-ylamino]-1-hydroxyethyl]-2-hydroxybenzamide
Medroxalol (RMI81968) is an orally active adrenergic receptor antagonist, blocks α- and β-adrenergic receptors· Medroxalol shows antihypertensive and vasodilating effects
ChemicalCAS56290-94-9MW372.41FormulaC20H24N2O5
- CAS number
- 56290-94-9
- Molecular weight
- 372.41
- Formula
- C20H24N2O5
- Solubility
- DMSO : 50 mg/mL (134·26 mM; Need ultrasonic)
- InChIKey
- MPQWSYJGFLADEW-UHFFFAOYSA-N
- Catalogue number
- GC65874
- Brand
- GLPBIO
Computed properties PubChem CID 41835 · XLogP 2.9 · TPSA 114 Ų · H-bond donors 4
- XLogP
- 2.9
- TPSA
- 114 Ų
- H-bond donors
- 4
- H-bond acceptors
- 6
- Rotatable bonds
- 8
- Heavy atoms
- 27
SMILES CC(CCC1=CC2=C(C=C1)OCO2)NCC(C3=CC(=C(C=C3)O)C(=O)N)O
Computed descriptors from PubChem (CID 41835), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il